Status:
COMPLETED
Oropharyngeal Colostrum for Immune Stimulation in Very Low Birth Weight Infants
Lead Sponsor:
Milton S. Hershey Medical Center
Collaborating Sponsors:
Children's Miracle Network
Conditions:
Very Low Birth Weight Infants
Eligibility:
All Genders
Up to 3 years
Phase:
NA
Brief Summary
Colostrum, mothers' early breastmilk, contains multiple factors that provide immune protection to very low birth weight (VLBW) infants, a population at high risk for hospital-acquired infections. Howe...
Eligibility Criteria
Inclusion
- infants with a birth weight less than 1500 grams (or 3.3 lbs) born at Penn State Hershey Medical Center and admitted to the PSUCH NICU immediately after birth
Exclusion
- Infants with major congenital anomalies or chromosomal syndromes incompatible with life Infants of mothers not willing to provide colostrum for their infant in the first week of life Infants of mothers with known HIV, Hepatitis B or Hepatitis C as these infections may be transmitted through breast milk
Key Trial Info
Start Date :
January 1 2011
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2013
Estimated Enrollment :
43 Patients enrolled
Trial Details
Trial ID
NCT01443091
Start Date
January 1 2011
End Date
December 1 2013
Last Update
May 30 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State Milton S. Hershey Medical Center
Hershey, Pennsylvania, United States, 17033